Page 8 - 51 the significance--29.2_opt
P. 8

Obesity is known to be the most common cause of insulin resistance. 16
          The exact relationship between the two is not fully understood, but it
          is thought to involve a number of processes, involving excessive stor-
          age of triglycerides in the liver (steatosis).  Lipids are more abundant
                                                  19
          in obese individuals and it is thought that these may interfere with the
          signalling processes crucial to the correct functioning of insulin.  Obes-
                                                                      20
          ity also triggers inflammatory responses, some of which are important in
          intracellular signalling within insulin-responsive cells.  Furthermore, the
                                                           20
          adipose tissue is far from being an inert storage ‘depot’ (see below). 20























          Figure 2. The consequences of insulin resistance. 21
          β-cell dysfunction

          The β-cells of the pancreas do not respond to rising glucose levels or
          other stimuli that regulate insulin secretion to match the current meta-
          bolic requirements. This results in a relative lack of insulin contributing
          to chronic hyperglycaemia, especially in the situation of insulin resist-
          ance with its higher insulin needs.  In the early stages of T2DM, with
                                           16
          the advent of resistance, there is a compensatory increase in insulin
          secretion in an attempt to maintain glucose and lipid homeostasis.
                                                                            17
          However, the time dynamics of insulin release is abnormal even at this
          stage because of a reduced sensitivity of β-cells to glucose. This de-
          fect is accentuated in overt T2DM. In long-standing disease, there is
          usually a reduction in the islet number and/or diminished β-cell mass
          in the pancreas of people with T2DM due to increased apoptosis and
          inadequate regeneration.  Why this should occur is not clear, but it
                                   22
          is likely to be due to a combination of genetic susceptibility and ac-
          quired factors. Many β-cell ‘aggressors’ have been identified, such as
          elevated glucose and free fatty acid levels (Figure 3), all of which lead
          to β-cell damage and apoptosis. For example, increased levels of free
          fatty acids within β-cells can inhibit proper glucose utilisation, disrupt
          normal cell signalling cascades and damage mitochondria due to the
                                           8
   3   4   5   6   7   8   9   10   11   12   13